HeartWare third-generation implantable continuous flow pump as biventricular support: mid-term follow-up

Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):458-60. doi: 10.1510/icvts.2010.250654. Epub 2010 Dec 20.

Abstract

A long-term mechanical biventricular support by HeartWare HVAS third-generation continuous flow pump (HeartWare, Inc, Miramar, FL, USA) was implanted in a Korean patient with a small chest size for treatment of a refractory end-stage heart failure due to an idiopathic dilative cardiomyopathy. We report our experience with a single patient and the early mid-term follow-up results with such a mechanical ventricular support.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Cardiomyopathy, Dilated / complications*
  • Heart Failure / diagnostic imaging
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart-Assist Devices* / adverse effects
  • Hemorrhage / drug therapy
  • Hemorrhage / etiology
  • Humans
  • Italy
  • Male
  • Prosthesis Design
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ventricular Function

Substances

  • Anticoagulants